Analyst Consensus
- Current Price
- 410.92 $
- Target (Low)
- 480.00 $
- Target (Mean)
- 532.81 $
- Target (High)
- 575.00 $
- Recommendation
- Strong Buy
- Number of Analysts
- 21
Recommendation Distribution
Recommendation Distribution| Strong Buy | 5 |
|---|
| Buy | 18 |
|---|
| Hold | 1 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 30.4%
- Operating Margin
- 44.3%
- Gross Margin
- 70.5%
- Return on Equity (ROE)
- 13.9%
- Return on Assets (ROA)
- 6.9%
- Revenue Growth
- 10.4%
- Earnings Growth
- 32.5%
- Debt/Equity
- 38.39
- Current Ratio
- 0.68
- Beta
- 1.08
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| May 5, 2026 | Mizuho | Outperform → Outperform |
| Apr 29, 2026 | JP Morgan | Overweight → Overweight |
| Apr 13, 2026 | Wells Fargo | Overweight → Overweight |
| Apr 7, 2026 | Morgan Stanley | Overweight → Overweight |
| Mar 17, 2026 | BMO Capital | Outperform → Outperform |
| Feb 17, 2026 | UBS | Buy → Buy |